Bright Eye Hospital Group Co., Ltd. (SHE:301239)
China · Delayed Price · Currency is CNY 32.44
-0.09 (-0.28%)
At close: Aug 3, 2026
Bright Eye Hospital Group Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,875 | 2,797 | 2,678 | 2,718 | 1,726 | 1,710 |
Revenue Growth | 4.76% | 4.44% | -1.46% | 57.50% | 0.91% | 25.54% |
Gross Profit Gross Profit Growth | 1,184 | 1,139 | 1,117 | 1,294 | 798.13 | 806.66 |
Operating Income Operating Income Growth | 177.8 | 136.01 | 88.92 | 360.37 | 92.47 | 176.83 |
Net Income Net Income Growth | -17.56 | -60.92 | -101.86 | 267.91 | 20.57 | 93.89 |
Earnings Per Share EPS Growth | -0.12 | -0.41 | -0.68 | 1.79 | 0.16 | 0.84 |
EPS Growth | - | - | - | 1018.75% | -80.95% | -13.40% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Refractive Items Refractive Items Growth | 1,297 | 1,227 | 1,296 | 970.67 | 872.18 |
Cataract Program Cataract Program Growth | 552.49 | 575.67 | 593.71 | 249.5 | 286.92 |
Optometry Item Optometry Item Growth | 419.31 | 386.43 | 396.76 | 259.91 | 276.01 |
Comprehensive Eye Disease Program Comprehensive Eye Disease Program Growth | 497.58 | 470.07 | 416.69 | 233.24 | 267.01 |
Others Others Growth | 0.56 | 0.28 | 1.86 | 1.24 | 0.5 |
Unallocated Other Operations Unallocated Other Operations Growth | 30.18 | 18.59 | 12.79 | 11.09 | 7.4 |
Total Total Growth | 2,797 | 2,678 | 2,718 | 1,726 | 1,710 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 571.72 | 430.43 | 501.16 | 836.7 | 926.23 | 170.77 |
Total Debt Total Debt Growth | 2,042 | 1,936 | 1,923 | 1,859 | 1,273 | 1,094 |
Net Cash (Debt) Net Cash Growth | -1,470 | -1,506 | -1,422 | -1,022 | -346.72 | -923.42 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -9.92 | -10.14 | -9.49 | -6.83 | -2.70 | -8.26 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 527.67 | 544.86 | 382.43 | 614.46 | 319.3 | 359.42 |
Capital Expenditures CapEx Growth | -205.88 | -226.41 | -542.86 | -626.87 | -327.99 | -254.8 |
Free Cash Flow Free Cash Flow Growth | 321.79 | 318.45 | -160.43 | -12.41 | -8.68 | 104.62 |
Free Cash Flow Growth | 467.09% | - | - | - | - | 29.30% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 41.17% | 40.71% | 41.70% | 47.61% | 46.25% | 47.17% |
Operating Margin | 6.18% | 4.86% | 3.32% | 13.26% | 5.36% | 10.34% |
Pretax Margin | 1.85% | 0.45% | -0.97% | 13.33% | 3.43% | 8.12% |
Profit Margin | -0.61% | -2.18% | -3.80% | 9.86% | 1.19% | 5.49% |
FCF Margin | 11.19% | 11.38% | -5.99% | -0.46% | -0.50% | 6.12% |
| Fiscal Year | FY 2023 | FY 2022 |
|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.400 | 0.100 |
Dividend Per Share Growth | 300.00% | - |
Dividend Yield | 0.47% | 0.14% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | - | 48.03 | 513.57 | - |
Forward PE | 64.88 | 20.30 | 62.74 | 40.00 | - | - |
P/FCF Ratio | 15.01 | 15.38 | - | - | - | - |
PS Ratio | 1.68 | 1.75 | 2.61 | 4.73 | 6.12 | - |